SK Biopharmaceuticals Launches Joint Venture with Eurofarma for AI-based Epilepsy Management Platform SK Biopharmaceuticals forms a joint venture, Mentis Care, to develop an integrated epilepsy care ecosystem through AI-driven platform commercialization. SEOUL, South Korea, Oct. 21, 2025 /PRNewswire/ — SK Biopharmaceuticals, Co., Ltd., a biotech company focusing on research, development, and commercialization of treatments for disorders of the central nervous system (CNS) […] The post SK Biopharmaceuticals Launches Joint Venture with Eurofarma first appeared on AsiaNewsToday.

SK Biopharmaceuticals Launches Joint Venture with Eurofarma #Biotechnology #EpilepsyManagement #AICare #HealthTech #JointVenture

One-third of people with epilepsy continue to have seizures despite new anti-seizure medications.
doi.org/10.1002/epi4...

#epilepsy #epilepsiaopen #ILAE #Delphiconsensusstudy #drugresistantepilepsy #DRE #epilepsymanagement #uncontrolledepilepsy

Research Participants Needed flyer for a study on epilepsy management and technology's role in it. Key details include eligibility criteria: 18+ years old, fluent in English, residing in the U.S., having epilepsy or being a caregiver/medical provider for people with epilepsy, and experience with technology (smartphones, tablets, etc.). Participants completing a one-hour Zoom interview will earn $15. Includes contact information for Dr. Afsaneh Razi (ar3882@drexel.edu) and a QR code linking to the survey page at Drexel University College of Computing & Informatics.

National #EpilepsyAwareness month may be over, but our work continues!
We are conducting a study on #epilepsy management and the technologies used for #epilepsy management. To participate, please fill out a short survey. Checkout flyer below! Thanks! Pls feel free to share! #EpilepsyManagement